Fundraising Fox

Oncodea

Saint Paul, US · Founded 2021 · Delaware corporation · 1 known investors

Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.

Founders & leadership

AK
Ali KhammanivongNamed on SEC filing
DQ
Dan Que PhamNamed on SEC filing
YY
Yung-Ping YehNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$275.8K disclosed across 1 round · 2022

$275.8KraisedApr 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ali KhammanivongDirector
  • Dan Que PhamExecutive Officer, Director
  • Yung-Ping YehDirector
Offering amount
$850K
Amount sold
$275.8K
Minimum investment
$25K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Oncodea for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Oncodea do?
Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.
Who are Oncodea's investors?
Oncodea's investors include GROOVE CAPITAL.
How much funding has Oncodea raised?
Oncodea has disclosed $275.8K raised across 1 round.
Where is Oncodea headquartered?
Oncodea is headquartered in Saint Paul, US.